These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22086884)

  • 21. Polymorphism rs4787951 in IL-4R contributes to the increased risk of renal cell carcinoma in a Chinese population.
    Lin Y; Yuan Q; Qian F; Qin C; Cao Q; Wang M; Chu H; Zhang Z
    Gene; 2019 Feb; 685():242-247. PubMed ID: 30472377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GNAS1 (Gαs) gene T393C polymorphism and renal cell carcinoma risk in a North Indian population: a case-control study.
    Arjumand W; Ahmad ST; Nafees S; Ali N; Rashid S; Seth A; Sultana S
    Genet Test Mol Biomarkers; 2012 Sep; 16(9):1062-6. PubMed ID: 22931242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective study of alcohol drinking and renal cell cancer risk in a cohort of finnish male smokers.
    Mahabir S; Leitzmann MF; Virtanen MJ; Virtamo J; Pietinen P; Albanes D; Taylor PR
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):170-5. PubMed ID: 15668492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicted plasma 25-hydroxyvitamin D and risk of renal cell cancer.
    Joh HK; Giovannucci EL; Bertrand KA; Lim S; Cho E
    J Natl Cancer Inst; 2013 May; 105(10):726-32. PubMed ID: 23568327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The correlation between low vitamin D status and renal interleukin-6/STAT3 hyper-activation in patients with clear cell renal cell carcinoma.
    Song J; Xu S; Zhang ZH; Chen YH; Gao L; Xie DD; Sun GP; Yu DX; Xu DX
    Steroids; 2019 Oct; 150():108445. PubMed ID: 31295461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Vascular Endothelial Growth Factor Gene Polymorphisms and Their Interactions with Environmental Factors on Susceptibility to Renal Cell Carcinoma.
    Liu F; Wen T; Tang Q; Chen F; Liao D
    Nephron; 2020; 144(5):255-260. PubMed ID: 32182617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of renal cell carcinoma and polymorphism in phase I xenobiotic metabolizing CYP1A1 and CYP2D6 enzymes.
    Ahmad ST; Arjumand W; Seth A; Nafees S; Rashid S; Ali N; Hamiza OO; Sultana S
    Urol Oncol; 2013 Oct; 31(7):1350-7. PubMed ID: 22281432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum 25-hydroxyvitamin D and risk of lung cancer in male smokers: a nested case-control study.
    Weinstein SJ; Yu K; Horst RL; Parisi D; Virtamo J; Albanes D
    PLoS One; 2011; 6(6):e20796. PubMed ID: 21695165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of human telomerase reverse transcriptase gene polymorphisms, serum levels, and telomere length with renal cell carcinoma risk and pathology.
    de Martino M; Taus C; Lucca I; Hofbauer SL; Haitel A; Shariat SF; Klatte T
    Mol Carcinog; 2016 Oct; 55(10):1458-66. PubMed ID: 26294352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The polymorphisms in the VHL and HIF1A genes are associated with the prognosis but not the development of renal cell carcinoma.
    Qin C; Cao Q; Ju X; Wang M; Meng X; Zhu J; Yan F; Li P; Ding Q; Chen J; Gu M; Zhang W; Yin C; Zhang Z
    Ann Oncol; 2012 Apr; 23(4):981-9. PubMed ID: 21778301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Germline genetic variations at 11q13 and 12p11 locus modulate age at onset for renal cell carcinoma.
    Audenet F; Cancel-Tassin G; Bigot P; Audouin M; Gaffory C; Ondet V; Thibault F; Auribault K; Gazut S; Benhabiles N; Azzouzi AR; Méjean A; Rouprêt M; Cussenot O
    J Urol; 2014 Feb; 191(2):487-92. PubMed ID: 23911636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High circulating insulin-like growth factor-1 reduces the risk of renal cell carcinoma: a Mendelian randomization study.
    Chen M; Tsai CW; Chang WS; Xiong GY; Xu Y; Bau DT; Gu J
    Carcinogenesis; 2021 Jun; 42(6):826-830. PubMed ID: 33852723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-16 polymorphism and risk of renal cell carcinoma: association in a Chinese population.
    Zhu J; Qin C; Yan F; Wang M; Ding Q; Zhang Z; Yin C
    Int J Urol; 2010 Aug; 17(8):700-7. PubMed ID: 20529140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association of DNA repair gene polymorphisms with the development and progression of renal cell carcinoma.
    Sakano S; Hinoda Y; Okayama N; Kawai Y; Korenaga Y; Eguchi S; Nagao K; Ohmi C; Naito K
    Ann Oncol; 2007 Nov; 18(11):1817-27. PubMed ID: 17712032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glutathione S-transferase M1, T1, and P1 polymorphisms as risk factors for renal cell carcinoma: a case-control study.
    Sweeney C; Farrow DC; Schwartz SM; Eaton DL; Checkoway H; Vaughan TL
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):449-54. PubMed ID: 10794492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The TERT locus genotypes of rs2736100-CC/CA and rs2736098-AA predict shorter survival in renal cell carcinoma.
    Ma R; Liu C; Lu M; Yuan X; Cheng G; Kong F; Lu J; Strååt K; Björkholm M; Ma L; Xu D
    Urol Oncol; 2019 May; 37(5):301.e1-301.e10. PubMed ID: 30738744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Relationship Between Urothelial Type Bladder Cancer, Plasma 25-Hydroxyvitamin D Levels, and Vitamin D Receptor ApaI BsmI FokI, and TaqI Polymorphisms.
    Baykan O; Akgul M; Uren N; Yaman A; Tinay I; Ergul E; Sazci A; Turkeri L; Haklar G
    Clin Lab; 2019 Apr; 65(4):. PubMed ID: 30969078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein E/C1 locus variants modify renal cell carcinoma risk.
    Moore LE; Brennan P; Karami S; Menashe I; Berndt SI; Dong LM; Meisner A; Yeager M; Chanock S; Colt J; Schwartz K; Davis F; Zaridze D; Mattveev V; Janout V; Kollarova H; Bencko V; Navratilova M; Szeszenia-Dabrowska N; Mates D; Holcatova I; Boffetta P; Chow WH; Rosenberg PS; Rothman N
    Cancer Res; 2009 Oct; 69(20):8001-8. PubMed ID: 19808960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genomic DNA Hypomethylation and Risk of Renal Cell Carcinoma: A Case-Control Study.
    Mendoza-Pérez J; Gu J; Herrera LA; Tannir NM; Matin SF; Karam JA; Huang M; Chang DW; Wood CG; Wu X
    Clin Cancer Res; 2016 Apr; 22(8):2074-82. PubMed ID: 26655847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of functional polymorphisms of cyclooxygenase 2 in renal cell carcinoma.
    Chang WS; Liao CH; Miao CE; Wu HC; Hou LL; Hsiao CL; Ji HX; Tsai CW; Bau DT
    Anticancer Res; 2014 Oct; 34(10):5481-6. PubMed ID: 25275044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.